Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients Multiple Sclerosis Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me